COMPASS Pathways plc (CMPS)
USD 3.09
(3.18%)
USD 3.09
(3.18%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -123.8 Million USD | -27.89% |
| 2022 | -110.4 Million USD | -28.11% |
| 2021 | -83.22 Million USD | -113.18% |
| 2020 | -47.03 Million USD | -92.78% |
| 2019 | -18.38 Million USD | -74.85% |
| 2018 | -10.51 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -47.89 Million USD | -5.28% |
| 2024 Q2 | -43.32 Million USD | -11.69% |
| 2024 Q1 | -38.57 Million USD | -12.56% |
| 2023 Q1 | -30.15 Million USD | -24.7% |
| 2023 FY | - USD | -41.74% |
| 2023 Q4 | -40.34 Million USD | -34.19% |
| 2023 Q3 | -30.06 Million USD | 4.29% |
| 2023 Q2 | -31.41 Million USD | -4.15% |
| 2022 Q2 | -25.04 Million USD | -5.33% |
| 2022 Q1 | -23.77 Million USD | 5.75% |
| 2022 FY | - USD | -28.11% |
| 2022 Q4 | -24.18 Million USD | -2.64% |
| 2022 Q3 | -23.56 Million USD | 5.92% |
| 2021 FY | - USD | -113.18% |
| 2021 Q4 | -25.22 Million USD | -12.28% |
| 2021 Q3 | -22.46 Million USD | -37.18% |
| 2021 Q2 | -16.37 Million USD | -44.08% |
| 2021 Q1 | -11.36 Million USD | -8.79% |
| 2020 Q1 | -7.68 Million USD | -21.94% |
| 2020 Q4 | -10.44 Million USD | -30.09% |
| 2020 Q3 | -8.03 Million USD | 54.5% |
| 2020 Q2 | -17.65 Million USD | -129.83% |
| 2020 FY | - USD | -92.78% |
| 2019 Q1 | -2.7 Million USD | 0.0% |
| 2019 FY | - USD | -74.85% |
| 2019 Q4 | -6.29 Million USD | -8.83% |
| 2019 Q3 | -5.78 Million USD | -59.64% |
| 2019 Q2 | -3.62 Million USD | -33.86% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 165.464% |
| Addus HomeCare Corporation | 106.55 Million USD | 216.183% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | 537.277% |
| Amedisys, Inc. | 216.91 Million USD | 157.074% |
| American Oncology Network, Inc. | -39.35 Million USD | -214.61% |
| Astrana Health, Inc. | 123.68 Million USD | 200.092% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 379.16% |
| IMAC Holdings, Inc. | -5.94 Million USD | -1981.827% |
| biote Corp. | 9.23 Million USD | 1440.719% |
| Cryo-Cell International, Inc. | -10.41 Million USD | -1088.428% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 195.722% |
| DocGo Inc. | 32.72 Million USD | 478.308% |
| The Ensign Group, Inc. | 353.23 Million USD | 135.048% |
| Healthcare Services Group, Inc. | 75.21 Million USD | 264.604% |
| InnovAge Holding Corp. | 1.15 Million USD | 10828.076% |
| Assure Holdings Corp. | -19.82 Million USD | -524.506% |
| The Joint Corp. | 9.14 Million USD | 1454.253% |
| LifeStance Health Group, Inc. | -104.92 Million USD | -17.99% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | -695.915% |
| ModivCare Inc. | -26.75 Million USD | -362.811% |
| NewGenIvf Group Limited | 384.3 Thousand USD | 32314.517% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | -2016.635% |
| Option Care Health, Inc. | 376.79 Million USD | 132.857% |
| P3 Health Partners Inc. | -81.07 Million USD | -52.708% |
| P3 Health Partners Inc. | -81.07 Million USD | -52.708% |
| The Pennant Group, Inc. | 30.36 Million USD | 507.659% |
| Surgery Partners, Inc. | 446.1 Million USD | 127.752% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | -4265.549% |
| Talkspace, Inc. | -22.01 Million USD | -462.404% |
| Talkspace, Inc. | -22.01 Million USD | -462.404% |
| The Oncology Institute, Inc. | -70.45 Million USD | -75.72% |
| The Oncology Institute, Inc. | -70.45 Million USD | -75.72% |